Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

83.62 +0.46 (+0.55%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Dow Dips Over 150 Points, But Records Weekly Gain: Investor Sentiment Improves, Greed Index In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Medtronic Unusual Options Activity For February 14
Via Benzinga
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga
9 Dividend Kings In The Next 5 Years
Here are 9 stocks have at least 45 years of dividend increases, meaning it’s just a matter of time until they reach the Dividend Kings list. 
Via Talk Markets
Topics Stocks / Equities
The Analyst Verdict: Medtronic In The Eyes Of 5 Experts
Via Benzinga
Is Medtronic's Dividend Safe?
Via The Motley Fool
1 Growth Stock Down 6% to Buy Right Now
Via The Motley Fool
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
Via The Motley Fool
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
3 Top Dividend Stocks I Plan to Buy in My Retirement Account in February
Via The Motley Fool
Topics Retirement
Exposures Pension
Looking Into Medtronic's Recent Short Interest
Via Benzinga
Neurotech Reports Announces First European Leaders Forum
SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch... 
Via Send2Press
The Smartest Dividend Stocks to Buy With $100 Right Now
Via The Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
This medtech giant is leveraging the power of artificial intelligence for a strong growth outlook. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Top Dividend Stock to Buy in 2025, and 1 to Avoid
Via The Motley Fool
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends
Via The Motley Fool
Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
The robotic-assisted surgery trend is accelerating and Intuitive Surgical continues to lead the pack as its continued to keeps its wide moat since 2000. 
Via MarketBeat
Exposures Product Safety
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
Via The Motley Fool
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:TDOC),(NASDAQ:TALK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
3 Incredible Dividend Stocks to Buy in 2025
These wildly successful companies are poised to keep your dividend portfolio healthy in 2025 and beyond. 
Via The Motley Fool
2 MedTech Stocks That Are Screaming Buys in January
Via The Motley Fool
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product
The company paused sales of a key product, a rival to Boston Scientific and Medtronic, due to safety concerns. 
Via Investor's Business Daily
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030. 
Via Benzinga
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
3 Stocks Helping to Bring AI to Healthcare
Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Dividend Stocks to Double Up on Right Now
If you are an avid dividend investor, here are three attractive dividend stocks you should accumulate now. 
Via The Motley Fool
4 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.